Potentiation of Anti-Tumor Efficacy Resulting from the Combined Administration of Interferon α and of an Anti-Breast Epithelial Monoclonal Antibody in the Treatment of Breasl Cancer Xenografts-Reference-Cited by-同舟云学术

Potentiation of Anti-Tumor Efficacy Resulting from the Combined Administration of Interferon α and of an Anti-Breast Epithelial Monoclonal Antibody in the Treatment of Breasl Cancer Xenografts

Published:1989 Issue: Volume: Page:195-201
ISSN:
Container-title:Breast Cancer Immunodiagnosis and Immunotherapy
language:
Short-container-title:

Author:

Ozzello Luciano,DeRosal Carolyn M.,Blank Edward W.,Cantell Kari,Habif David V.,Ceriani Roberto L.

Publisher

Springer US

Link

http://link.springer.com/content/pdf/10.1007/978-1-4757-1296-4_18.pdf

Reference14 articles.

1. L. Ozzello, D.V. Habif, C.M. DeRosa, and K. Cantell, Treatment of human breast cancer xenografts using natural interferons α and-l $injected singly or in combination, J. Interferon Res. 8:679(1988)$

2. P. von Wussow, B. Berthold, F. Hartmann, and H. Deicher, Intralesional interferon-alpha therapy in advanced malignant melanoma, Cancer 61 :1071(1988).

3. S.S. Alkan, S. Miescher-Granger, D.G. Braun, and H.K. Hochkeppel, Anti vi ral and antiproliferative effects of interferons delivered via monoclonal antibodies, J.Interferon Res. 4:355(1984).

4. R. Tran, P. Horan Hand, J.W. Greiner, S. Pestka, and J. Schlom, Enhancement of surface antigen expression on human breast carcinoma cells by recombinant human interferons, J.Interferon Res. 8:75(1988).

5. J.W. Greiner, F. Guadagni, P. Noguchi, S. Pestka, D. Colcher, P.B. Fisher, and J. Schlom, Recombinant interferon enhances monoclonal antibody-targeting of carcinoma lesions in vivo, Science 235:895(1987).

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Conjugation of interferon alpha to a humanized monoclonal antibody (HuBrE-3vl) enhances the selective localization and antitumor effects of interferon in breast cancer xenografts;Breast Cancer Research and Treatment;1998-03

2. The use of natural interferon alpha conjugated to a monoclonal antibody anti mammary epithelial mucin (Mc5) for the treatment of human breast cancer xenografts;Breast Cancer Research and Treatment;1993-01